Ying Zhou, PhD
About Ying Zhou, PhD
Ying Zhou, PhD, is the Director at Alkermes with extensive experience in proteomics and drug discovery. She holds a Ph.D. in Biochemistry from Boston University School of Medicine and has previously worked at AmberGen Inc. and AstraZeneca.
Current Role at Alkermes
Ying Zhou, PhD, serves as a Director at Alkermes. Since joining Alkermes in April 2016, she has undertaken significant responsibilities in various domains. Her role encompasses leadership in scientific and strategic initiatives, contributing to the company's growth and development in the pharmaceutical sector.
Previous Experience at AmberGen Inc.
Before joining Alkermes, Ying Zhou, PhD, worked at AmberGen Inc. from 2014 to 2016 as Project Leader in Proteomics & Drug Discovery. Based in Watertown, MA, her focus was on advancing research and development in proteomics, contributing extensively to drug discovery projects. This role provided her with substantial experience in proteomics and drug discovery.
Role at AstraZeneca
Ying Zhou, PhD, held the position of Senior Scientist at AstraZeneca in Waltham, MA, from 2013 to 2014. During this tenure, she contributed to various scientific research projects, leveraging her expertise in biochemistry and analytical chemistry to support AstraZeneca's pharmaceutical research initiatives.
Educational Background
Ying Zhou, PhD, possesses a robust educational background in the field of chemistry and biochemistry. She obtained her Doctor of Philosophy (Ph.D.) in Biochemistry from Boston University School of Medicine. Prior to this, she earned a Master of Science (M.S.) in Analytical Chemistry from the Chinese Academy of Sciences and a Bachelor's Degree in Chemistry from the University of Science and Technology of China. Her educational qualifications have substantially equipped her for her roles in research and drug discovery.